Long Qt Syndrome 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Long QT syndrome 2 (LQT2) is caused by mutations in the human ether-a-go-go-related gene (hERG).
|
27803431 |
2016 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
KCNH2 gene mutations disrupting rapid component of I(K) (I(Kr)) underlie type 2 congenital long QT syndrome (LQT2).
|
19419905 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
KCNH2 mutations cause type 2 long QT syndrome (LQT2), which increases the risk for life-threatening ventricular arrhythmias.
|
23546015 |
2013 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
T1945+6C is a disease-causing mutation.It alters KCNH2 splicing and cosegregates with the LQT2 phenotype.
|
15364333 |
2004 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
|
7889573 |
1995 |
Long Qt Syndrome 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
|
7889573 |
1995 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A mutation in HERG associated with notched T waves in long QT syndrome.
|
8877771 |
1996 |
Long Qt Syndrome 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel KCNH2 mutation as a modifier for short QT interval.
|
18692916 |
2009 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
|
12354768 |
2002 |
Long Qt Syndrome 2
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Along the same line of development of gene-specific therapy, recent data demonstrated that an increase in the extracellular concentration of potassium shortens the QT interval in LQT2 patients suggesting that intervention aimed at increasing potassium plasma levels may represent a specific treatment for LQT2.
|
9272507 |
1997 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG.
|
11170080 |
2001 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence.
|
10086971 |
1999 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.
|
12062363 |
2002 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome.
|
10517660 |
1999 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome.
|
12621127 |
2003 |
Long Qt Syndrome 2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
|
15840476 |
2005 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
|
15840476 |
2005 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
|
15840476 |
2005 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Compound Mutations Cause Increased Cardiac Events in Children with Long QT Syndrome: Can the Sequence Homology-Based Tools be Applied for Prediction of Phenotypic Severity?
|
27041096 |
2016 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Compound mutations: a common cause of severe long-QT syndrome.
|
15051636 |
2004 |
Long Qt Syndrome 2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.
|
29085299 |
2017 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
|
24057343 |
2014 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
|
27816319 |
2017 |
Long Qt Syndrome 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Defective functional PM expression of the human ether-a-go-go-related gene (hERG) K(+) channel leads to the prolongation of the ventricular action potential that causes long QT syndrome 2 (LQT2), with increased propensity for arrhythmia and sudden cardiac arrest.
|
24152733 |
2013 |